A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder

Condition	Treatment or Intervention	Phase
Seasonal Affective Disorder (SAD)	Drug: Investigational Seasonal Affective Disoder (SAD) drug	Phase III

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria: (Patient must meet these criteria in order to be eligible for this study.)

• Patient has a history of Major Depressive Disorder (MDD) with a seasonal pattern

Exclusion Criteria: (Patient cannot meet these criteria in order to be eligible for this study.)

• Patient has a current or past history of seizure disorder or brain injury
• Patient has a history or current diagnosis of anorexia nervousa or bulimia
• Patient has recurrent summer depression more frequently than winter depression
• Patient has primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders
• Patient has initiated psychotherapy within the last 3 months

Alaska
      Anchorage,  Alaska,  99508,  United States
Connecticut
      Hamden,  Connecticut,  06518,  United States
Idaho
      Boise,  Idaho,  83702,  United States
Illinois
      Oak Brook,  Illinois,  60523,  United States
      Edwardsville,  Illinois,  62025,  United States
      Chicago,  Illinois,  60637,  United States
      Oakbrook Terrace,  Illinois,  60181,  United States
Indiana
      Lafayette,  Indiana,  47905,  United States
Iowa
      Cedar Rapids,  Iowa,  52401,  United States
Kansas
      Overland Park,  Kansas,  66211,  United States
Maryland
      Baltimore,  Maryland,  21204,  United States
      Rockville,  Maryland,  20852,  United States
      Rockville,  Maryland,  20852,  United States
Massachusetts
      Belmont,  Massachusetts,  02478,  United States
Michigan
      Farmington Hills,  Michigan,  48334,  United States
      Detroit,  Michigan,  48207,  United States
      Farmington Hills,  Michigan,  48334,  United States
Minnesota
      Minneapolis,  Minnesota,  55454,  United States
Missouri
      St. Louis,  Missouri,  63108,  United States
Nebraska
      Omaha,  Nebraska,  68196,  United States
New Jersey
      Clementon,  New Jersey,  08021,  United States
      Princeton,  New Jersey,  08540,  United States
      Kenilworth,  New Jersey,  07033,  United States
New York
      Rochester,  New York,  14618,  United States
      Albany,  New York,  12208,  United States
      New York,  New York,  10021,  United States
      New York,  New York,  10024,  United States
      New York,  New York,  10025,  United States
Ohio
      Beachwood,  Ohio,  44122,  United States
      Dayton,  Ohio,  45415,  United States
      Cincinnati,  Ohio,  45267,  United States
      Marion,  Ohio,  43302,  United States
Oregon
      Eugene,  Oregon,  97401,  United States
      Lake Oswego,  Oregon,  97035,  United States
      Portland,  Oregon,  97237,  United States
      Eugene,  Oregon,  97401,  United States
Pennsylvania
      Jenkintown,  Pennsylvania,  19046,  United States
      Havertown,  Pennsylvania,  19083,  United States
      Philadelphia,  Pennsylvania,  19131,  United States
Rhode Island
      East Providence,  Rhode Island,  02915,  United States
Vermont
      Woodstock,  Vermont,  05091,  United States
Virginia
      Falls Church,  Virginia,  22041,  United States
Washington
      Seattle,  Washington,  98105,  United States
      Spokane,  Washington,  99204,  United States
      Bellevue,  Washington,  98004,  United States
Wisconsin
      Brown Deer,  Wisconsin,  53223,  United States
Canada, Alberta
      Calgary,  Alberta,  T2X 2A8,  Canada
      Edmonton,  Alberta,  T6L 5X8,  Canada
Canada, British Columbia
      Kelowna,  British Columbia,  V1Y 2A3,  Canada
Canada, Manitoba
      Winnipeg,  Manitoba,  R3E 3N4,  Canada
Canada, Ontario
      Toronto,  Ontario,  M9W 4L6,  Canada
      Toronto,  Ontario,  M4T 1K2,  Canada
Canada, Quebec
      Sherbrooke,  Quebec,  J1G 1W4,  Canada
      Montreal,  Quebec,  H2L 1H9,  Canada

Study ID Numbers:  AK130930
Record last reviewed:  July 2004
Last Updated:  October 13, 2004
Record first received:  September 24, 2002
ClinicalTrials.gov Identifier:  NCT00046241
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08